Search results

  1. 1.
    0559889 - ÚOCHB 2023 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
    Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
    2022. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 10.05.2022. Patent Number: US11325931
    Institutional support: RVO:61388963
    Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/patent/search/family/055264571/publication/US11325931B2?q=US11325931B2
    Permanent Link: https://hdl.handle.net/11104/0333018

               
     
     
  2. 2.
    0559886 - ÚOCHB 2023 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Krečmerová, Marcela - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej
    Prodrugs of prostate specific membrane antigen (PSMA) inhibitor.
    2022. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 12.01.2022. Patent Number: EP3177632
    Institutional support: RVO:61388963
    Keywords : 2-Phosphonomethylpentanedioic acid (2-PMPA) * glutamate carboxypeptidase II * GCPII * PSMA * pivaloyloxymethyl * isopropyloxycarbonyloxymethyl * POM * POC * prodrug
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/patent/search/family/055264571/publication/EP3177632B1?q=EP3177632B1
    Permanent Link: https://hdl.handle.net/11104/0333015

               
     
     
  3. 3.
    0549178 - ÚOCHB 2022 RIV eng P - Patent Document
    Stříšovský, Kvido - Majer, Pavel - Stanchev, Stancho - Tichá, Anežka
    Peptidyl ketoamides as inhibitors of rhomboid proteases.
    2021. Owner: Ústav organické chemie a biochemie AV ČR v.v.i. Date of the patent acceptance: 27.10.2021. Patent Number: EP3638686
    R&D Projects: GA MŠk(CZ) LK11206; GA MŠk LO1302
    EU Projects: European Commission(XE) 304154 - Rhomboid substrates
    Grant - others:EMBO(DE) 2329
    Institutional support: RVO:61388963
    Keywords : rhomboid protease * inhibitor * ketoamide
    OECD category: Biochemistry and molecular biology
    https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=EP&NR=3638686B1&KC=B1&FT=D&ND=4&date=20211027&DB=&locale=en_EP
    Permanent Link: http://hdl.handle.net/11104/0325195

               
     
     
  4. 4.
    0544774 - ÚOCHB 2022 RIV eng P - Patent Document
    Slusher, B. S. - Rais, R. - Vávra, Jan - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej - Tenora, Lukáš
    Prodrug compositions and utility of hydroxamate-based GCPII inhibitors.
    2021. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 13.07.2021. Patent Number: US11059775
    Institutional support: RVO:61388963
    Keywords : hydroxamate * prodrugs * GCPII inhibitors
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
    Permanent Link: http://hdl.handle.net/11104/0321584

               
     
     
  5. 5.
    0543605 - ÚOCHB 2022 RIV eng P - Patent Document
    Stříšovský, Kvido - Majer, Pavel - Stanchev, Stancho - Tichá, Anežka
    Peptidyl ketoamides as inhibitors of rhomboid proteases.
    2021. Owner: Ústav organické chemie a biochemie AV ČR v.v.i. Date of the patent acceptance: 23.02.2021. Patent Number: US10927146
    R&D Projects: GA MŠk(CZ) LK11206; GA MŠk LO1302
    EU Projects: European Commission(XE) 304154 - Rhomboid substrates
    Grant - others:EMBO(DE) 2329
    Institutional support: RVO:61388963
    Keywords : rhomboid protease * inhibitor * ketoamide
    OECD category: Biochemistry and molecular biology
    https://worldwide.espacenet.com/patent/search/family/059358276/publication/US10927146B2?q=US10927146
    Permanent Link: http://hdl.handle.net/11104/0320793

               
     
     
  6. 6.
    0543377 - ÚOCHB 2022 RIV cze P - Patent Document
    Šácha, Pavel - Konvalinka, Jan - Schimer, Jiří - Knedlík, Tomáš - Navrátil, Václav - Tykvart, Jan - Sedlák, František - Majer, Pavel - Cígler, Petr - Šubr, Vladimír - Ulbrich, Karel - Strohalm, Jiří
    Makromolekulární konjugáty pro vizualizaci a separaci proteinů a buněk.
    [Macromolecular conjugates for visualizing and separating proteins and cells.]
    2021. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. - Ústav makromolekulární chemie AV ČR, v. v. i. - Univerzita Karlova. Date of the patent acceptance: 22.04.2021. Patent Number: 308807
    R&D Projects: GA MŠk LO1302; GA ČR(CZ) GA16-02938S
    Institutional support: RVO:61388963 ; RVO:61389013
    Keywords : antibody mimetics * flow cytometry * ELISA * protein targeting * polymer conjugates * molecular recognition * HPMA
    OECD category: Biochemistry and molecular biology; Polymer science (UMCH-V)
    https://isdv.upv.cz/doc/FullFiles/Patents/FullDocuments/308/308807.pdf
    Permanent Link: http://hdl.handle.net/11104/0320591

               
     
     
  7. 7.
    0541959 - ÚOCHB 2022 RIV jpn P - Patent Document
    Slusher, B. - Rais, R. - Tenora, Lukáš - Majer, Pavel - Jančařík, Andrej
    グルタミン類似体のプロドラッグ.
    [Prodrugs of glutamine analogs.]
    2021. Owner: The Johns Hopkins University. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.04.2021. Patent Number: JP6863981
    Institutional support: RVO:61388963
    Keywords : 6-diazo-5-oxo-L-norleucine (DON) * prodrugs * cancer
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210421&DB=&locale=en_EP&CC=JP&NR=6863981B2&KC=B2&ND=5
    Permanent Link: http://hdl.handle.net/11104/0319470

               
     
     
  8. 8.
    0541954 - ÚOCHB 2022 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Tenora, Lukáš - Majer, Pavel - Jančařík, Andrej
    Prodrugs of glutamine analogs.
    2021. Owner: The Johns Hopkins University. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 23.03.2021. Patent Number: US10954257
    Institutional support: RVO:61388963
    Keywords : 6-diazo-5-oxo-L-norleucine (DON) * prodrugs * cancer
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210323&DB=&locale=en_EP&CC=US&NR=10954257B2&KC=B2&ND=5
    Permanent Link: http://hdl.handle.net/11104/0319466

               
     
     
  9. 9.
    0541346 - ÚOCHB 2022 RIV rus P - Patent Document
    Slusher, B. - Rais, R. - Tenora, Lukáš - Majer, Pavel - Jančařík, Andrej
    Пролекарства аналогов глутамина.
    [Prodrugs of glutamine analogs.]
    2020. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.02.2020. Patent Number: EA034571
    Institutional support: RVO:61388963
    Keywords : 6-diazo-5-oxo-L-norleucine (DON) * prodrugs * cancer
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=EA&NR=034571B1&KC=B1&FT=D&ND=4&date=20200221&DB=&locale=en_EP
    Permanent Link: http://hdl.handle.net/11104/0318923

               
     
     
  10. 10.
    0541336 - ÚOCHB 2022 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Tenora, Lukáš - Majer, Pavel - Jančařík, Andrej
    Prodrugs of glutamine analogs.
    2021. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. - The Johns Hopkins University. Date of the patent acceptance: 04.02.2021. Patent Number: AU2016302940
    Institutional support: RVO:61388963
    Keywords : 6-diazo-5-oxo-L-norleucine (DON) * prodrugs * cancer
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210204&DB=&locale=en_EP&CC=AU&NR=2016302940B2&KC=B2&ND=4
    Permanent Link: http://hdl.handle.net/11104/0318907

               
     
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.